Genome-wide DNA methylation profiling of non-small cell lung carcinomas

Table 1 Data from patients used for MethylCap-seq and bisulfite sequencing validation

Sample ID	Tissue type	Patient ID	Stage	Overall survival (month)	Survival status	Gender	Age at diagnosis	Ethnicity
2213 N	healthy	SCC1	IIB	2,43	Alive	M	54,54	Caucasian
2214 T	SCC	SCC1	IIB	2,43	Alive	M	54,54	Caucasian
2235 N	healthy	SCC2	IIB	51,23	Deceased	M	73,73	Caucasian
2236 T	SCC	SCC2	IIB	51,23	Deceased	M	73,73	Caucasian
2245 N	healthy	ADC1	IB	12,57	Alive	F	66,26	Caucasian
2246 T	ADC	ADC1	IB	12,57	Alive	F	66,26	Caucasian
2255 N	healthy	ADC2	IA	98,93	Deceased	F	54,26	Caucasian
2256 T	ADC	ADC2	IA	98,93	Deceased	F	54,26	Caucasian
2257 N	healthy	ADC3	N/A	N/A	N/A	M	78,96	Caucasian
2258 T	ADC	ADC3	N/A	N/A	N/A	M	78,96	Caucasian
2261 N	healthy	SCC3	IIB	6,77	Alive	M	70,03	Caucasian
2262 T	SCC	SCC3	IIB	6,77	Alive	M	70,03	Caucasian
22he	healthy	LCC1	IB	35,73	Deceased	F	56,58	Caucasian
22tu	LCC	LCC1	IB	35,73	Deceased	F	56,58	Caucasian

ADC: adenocarcinoma; LCC: large cell carcinoma; N/A: not applicable; SCC: Squamous cell carcinoma.

ISSN: 1756-8935